Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
24.90
-1.61 (-6.07%)
Feb 27, 2026, 3:00 PM CST

SHA:605033 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,3661,6262,4272,3593,611-
Market Cap Growth
14.22%-32.98%2.88%-34.67%--
Enterprise Value
2,8731,1762,1262,0603,339-
Last Close Price
24.9011.9417.5416.5325.60-
PE Ratio
113.4144.1342.1616.2628.72-
PS Ratio
3.861.843.472.604.29-
PB Ratio
2.931.452.182.173.74-
P/TBV Ratio
3.261.622.352.203.77-
P/FCF Ratio
60.3913.3818.51137.78--
P/OCF Ratio
13.495.807.2518.66--
EV/Sales Ratio
3.301.333.042.273.96-
EV/EBITDA Ratio
130.1229.9333.3413.7324.63-
EV/EBIT Ratio
-62.3149.5615.3127.13-
EV/FCF Ratio
51.549.6716.22120.32--
Debt / Equity Ratio
0.130.070.00-0.03-
Debt / EBITDA Ratio
6.791.860.02-0.20-
Debt / FCF Ratio
2.690.600.01---
Net Debt / Equity Ratio
-0.43-0.52-0.43-0.37-0.39-0.44
Net Debt / EBITDA Ratio
-22.34-14.84-7.53-2.66-2.77-2.09
Net Debt / FCF Ratio
-8.85-4.80-3.66-23.341.74-15.14
Asset Turnover
0.480.500.430.600.750.78
Inventory Turnover
3.572.121.181.041.271.43
Quick Ratio
1.421.211.391.691.140.73
Current Ratio
1.991.782.333.212.731.95
Return on Equity (ROE)
2.61%3.29%5.23%14.13%17.76%19.20%
Return on Assets (ROA)
0.07%0.66%1.65%5.56%6.84%7.32%
Return on Invested Capital (ROIC)
0.26%3.13%5.99%20.05%25.66%33.97%
Return on Capital Employed (ROCE)
0.10%1.50%3.50%11.30%12.00%17.90%
Earnings Yield
0.88%2.27%2.37%6.15%3.48%-
FCF Yield
1.66%7.48%5.40%0.73%-5.96%-
Dividend Yield
0.57%1.21%0.85%1.33%0.74%-
Payout Ratio
72.45%76.62%51.82%18.38%2.62%0.89%
Buyback Yield / Dilution
-1.18%-1.99%1.29%-22.93%-9.27%-1.93%
Total Shareholder Return
-0.67%-0.78%2.14%-21.60%-8.53%-1.93%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.